RD-Connect members, often in collaboration with external partners, have developed several bioinformatic tools to help researchers analyse omics data and identify targets for potential therapies. These include variant analysis and annotation tools as well as therapeutic prediction tools and gene-drug interaction resources, many of which are integrated in the Genome-Phenome Analysis Platform.

The work on developing the bioinformatic tools within RD-Connect is led by  Aix-Marseille University Medical School (AMU), France.